Real-world cardiovascular risks with novel hormonal therapies in advanced prostate cancer

Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC

ASCO GU 2026: Updates in renal cancer

FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma

From lived experience to informed choice in breast cancer reconstruction

Transforming radiotherapy skin care by recognising diverse skin reactions

COVID-19 IgG antibodies induce endothelial activation, barrier dysfunction, and a prothrombotic state

Complement-bound procoagulant platelets predict thrombosis in antiphospholipid syndrome

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor-associated thrombosis

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients

ESMO 2025: Highlights and analysis

Best practice in precision medicine for prostate cancer